Avidity Biosciences
RNAM
#1905
Rank
A$15.95 B
Marketcap
A$103.28
Share price
0.00%
Change (1 day)
79.04%
Change (1 year)

Market capitalization of Avidity Biosciences (RNAM)

Market cap: A$15.95 Billion

As of August 2026 Avidity Biosciences has a market cap of A$15.95 Billion. This makes Avidity Biosciences the world's 1905th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences in 2026

End of year Market Cap

Year Marketcap Change
2026A$15.95 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$205.41 B 1,187.46%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$146.37 B 817.44%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
A$2.45 B-84.62%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
A$8.17 B-48.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
A$0.42 B-97.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$1.16 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
A$15.50 B-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$5.46 B-65.73%๐Ÿ‡บ๐Ÿ‡ธ USA